Fortune Pharmaceutical Co
Fortune Pharmaceutical Co., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of innovative healthcare solutions. Specialising in a diverse range of products, including generic medications and active pharmaceutical ingredients, Fortune Pharmaceutical Co. is recognised for its commitment to quality and efficacy. The company’s unique approach to research and development has led to significant advancements in therapeutic areas such as oncology and cardiology. With a strong market position, Fortune Pharmaceutical Co. has achieved notable milestones, including partnerships with global healthcare providers and a robust portfolio of patented formulations. This dedication to excellence continues to drive the company’s growth and reputation in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Fortune Pharmaceutical Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fortune Pharmaceutical Co's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Fortune Pharmaceutical Co's reported carbon emissions
Fortune Pharmaceutical Co, headquartered in China (CN), currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This lack of information suggests that Fortune Pharmaceutical Co may not have established formal commitments to reduce its carbon footprint or engage in climate action initiatives at this time. In the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set measurable targets to mitigate their environmental impact. Without specific data or commitments, it is challenging to assess Fortune Pharmaceutical Co's position in the context of climate responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fortune Pharmaceutical Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
